American Society of Hematology

SHERPA: Blue

People

  1. Shukla
    Shukla
  2. O'Reilly
    O'Reilly
  3. Kernan
    Kernan
  4. Trippett
    Trippett
  5. Scaradavou
    Scaradavou
  6. Wolden
    Wolden
  7. Curran
    Curran
  8. Kung
    Kung
  9. Forlenza
    Forlenza
  10. Papadopoulos
    Papadopoulos

Groups

  1. Center for Hematologic Malignancies (117)
  2. Pediatric Leukemia (117)
  3. Pediatrics, Department of (107)
  4. Hematologic Malignancies Service (96)
  5. Department of Medicine (53)
  6. GSK Faculty (39)
  7. Stem Cell Transplantation and Cellular Therapy Service (39)
  8. Tow Center for Developmental Oncology (TCDO) (39)
  9. Center for Molecular Imaging and Biotechnology (CMIB) (38)
  10. Hematologic Malignancies, Division of (35)
Search Within
  1. "Pediatric Leukemia"
Formats
  1. Meeting Abstract (89)
  2. Journal Article (26)
  3. Research Letter (2)
Groups
  1. Center for Hematologic Malignancies (117)
  2. Pediatric Leukemia (117)
  3. Pediatrics, Department of (107)
  4. Hematologic Malignancies Service (96)
  5. Department of Medicine (53)
  6. GSK Faculty (39)

More Groups

People
  1. Peter Steinherz (57)
  2. Neerav Shukla (33)
  3. Richard O'Reilly (30)
  4. Nancy Kernan (25)
  5. Farid Boulad (24)
  6. Tanya Trippett (24)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (5)
  4. 2022 (5)
  5. 2021 (3)
  6. 2020 (1)

More Years

Publications
  1. Blood (110)
  2. Blood Advances (6)
  3. Hematology-American Society of Hematology Education Program (1)

Results (117)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Supernumerary ring chromosome 1 syndrome leads to fusion-driven B-cell acute lymphoblastic leukemia in monozygotic twins
    Research Letter

    Gutiérrez-Abril, J.; Gundem, G.; Fiala, E.; Liosis, K.; Farnoud, N.; Leongamornlert, D.; Amallraja, A.; Arango-Ossa, J. E.; Domenico, D.; Levine, M.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • A phase II study of the menin inhibitor revumenib in leukemia associated with upregulation of HOX genes: Trial in progress
    Meeting Abstract

    Issa, G. C.; Chin, K. K.; Blachly, J. S.; Farhat, A.; Xiao, L.; Ning, J.; Cuglievan, B.; Shukla, N.; Sasaki, K.; Loghavi, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Updated results and longer follow-up from the AUGMENT-101 phase 2 study of revumenib in all patients with relapsed or refractory (R/R) KMT2Ar acute leukemia
    Meeting Abstract

    Aldoss, I.; Issa, G. C.; Blachly, J. S.; Thirman, M. J.; Mannis, G. N.; Arellano, M. L.; DiPersio, J. F.; Traer, E.; Zwaan, C. M.; Shukla, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Radiation therapy for Burkitt lymphoma: Multi-decade insights from a single center
    Meeting Abstract

    Tward, A.; Patel, R. R.; Isgor, I.; Galera, P.; Lopez, K.; Fregonese, B.; Moore, Z.; Wolden, S.; Yahalom, J.; Imber, B. S.
    Blood (2024)

    Fulltext@MSK | Save
  • Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: The DELPHINUS study
    Journal Article

    Bhatla, T.; Hogan, L. E.; Teachey, D. T.; Bautista, F.; Moppett, J.; Velasco Puyó, P.; Micalizzi, C.; Rossig, C.; Shukla, N.; Gilad, G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Revumenib monotherapy in patients with relapsed/refractory KMT2Ar acute leukemias: Efficacy and safety results from the AUGMENT-101 phase 1/2 study
    Meeting Abstract

    Aldoss, I.; Issa, G. C.; Thirman, M. J.; DiPersio, J.; Arellano, M.; Blachly, J. S.; Mannis, G.; Perl, A.; Dickens, D.; McMahon, C. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A de novo supernumerary ring chromosome 1 causes B-cell acute lymphoblastic leukemia in monozygotic twins due to independent and partially convergent evolutionary trajectories
    Meeting Abstract

    Gutiérrez-Abril, J.; Gundem, G.; Fiala, E.; Liosis, K.; Farnoud, N.; Leongamornlert, D.; Amallraja, A.; Ossa, J. E. A.; Domenico, D.; Levine, M. F.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Performance of positron emission tomography at diagnosis and response assessment in low and intermediate-risk nodular lymphocyte predominant Hodgkin lymphoma
    Meeting Abstract

    Marks, L. J.; McCarten, K.; Pei, Q.; Wu, Y.; Kelly, K. M.; Schwartz, C.; Wolden, S.; Friedman, D. L.; Castellino, S. M.; Appel, B.
    Blood (2023)

    Fulltext@MSK | Save
  • Revumenib monotherapy in patients with relapsed/refractory KMT2Ar acute leukemia: Topline efficacy and safety results from the pivotal Augment-101 phase 2 study
    Meeting Abstract

    Aldoss, I.; Issa, G. C.; Thirman, M.; DiPersio, J.; Arellano, M.; Blachly, J. S.; Mannis, G. N.; Perl, A.; Dickens, D. S.; McMahon, C. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clonal hematopoiesis in survivors of childhood cancer
    Research Letter

    Friedman, D. N.; Chan, I. C. C.; Moskowitz, C. S.; Li, S.; Turner, K.; Liu, J.; Bouvier, N.; Walsh, M. F.; Spitzer, B.; Kung, A. L.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save